{"has_more":true,"total_items":35,"items":[{"vg_id":0,"journal":"§203(a),(specifying the conditions under which the federal government can \"march-in\")","authors":[{"author_name":"U S"}]},{"vg_id":0,"published_date":2012,"journal":"Nᴀᴛᴜʀᴇ Bɪᴏᴛᴇᴄʜɴᴏʟᴏɢʏ","volume":30,"title":"Accountability in Patenting of Federally Funded Research","authors":[{"author_name":"K Arti"},{"author_name":"N Rai & Bhaven"},{"author_name":" Sampat"}]},{"vg_id":0,"published_date":"2020-10-21","journal":"Deconstructing Moderna's COVID-19 Patent Pledge, Hᴀʀᴠᴀʀᴅ L. Pᴇᴛʀɪᴇ Fʟᴏᴍ Cᴛʀ","authors":[{"author_name":"Jorge L Contreras"}]},{"vg_id":0,"authors":[{"author_name":" Id"}]}]}